Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Alpha 1-antitrypsin deficiency screening
Introduction
Overview
Overview
According to the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), all COPD patients should be screened for AATD at least once in their lifetime. All patients with unexplained liver disease with or without respiratory symptoms should be evaluated for AATD.
Screening
Screening
Screening for alpha 1-antitrypsin deficiency includes:[1][2]
- According to the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), all COPD patients should be screened for AATD at least once in their lifetime.
- All patients with unexplained liver disease with or without respiratory symptoms should be evaluated for AATD.
- Adults with necrotizing panniculitis should be screened.
References
References
- ↑ Hersh CP (2017). “Diagnosing alpha-1 antitrypsin deficiency: the first step in precision medicine”. F1000Res. 6: 2049. doi:10.12688/f1000research.12399.1. PMC 5710307. PMID 29225784.
- ↑ Lascano JE, Campos MA (2017). “The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency”. Postgrad Med. 129 (8): 889–895. doi:10.1080/00325481.2017.1381539. PMID 28929906.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]